The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease

被引：43
作者：
Brunelli, T
Bagnoli, S
Giusti, B
Nacmias, B
Pepe, G
Sorbi, S
Abbate, R
机构：
[1] Univ Florence, Dept Neurol & Psychait Sci, I-50134 Florence, Italy
[2] Univ Florence, Sect Clin Med & Cardiol, Dept Med & Surg Crit Care, Florence, Italy
来源：
NEUROSCIENCE LETTERS | 2001年 / 315卷 / 1-2期
关键词：
Alzheimer's disease; methylenetetrahydrofolate reductase; genetics; apolipoprotein E; polymorphism;
D O I：
10.1016/S0304-3940(01)02316-3
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The methylenetetrahydrofolate reductase (MTHFR) gene has been recently considered as a candidate gene for Alzheimer's disease (AD). MTHFR is a key enzyme in the metabolism of homocysteine and elevated levels of that amino acid have been associated to Vascular Dementia and AD. AT --> C transition at codon 677 produces a thermolabile type of the enzyme. However, contrasting results on the distribution of the MTHFR C677T common polymorphism in AD have been published. We analyzed the distribution of the MTHFR and apolipoprotein E (APOE) polymorphisms in Italian patients with sporadic AD. The distribution of the C677T polymorphism did not differ in AD and controls. Our data suggest that the MTHFR polymorphism does not contribute to genetic susceptibility in Italian sporadic AD and does not mitigate the effect of ApoE epsilon4 allele on AD risk. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：103 / 105
页数：3
相关论文
共 19 条
[1]  
Abbate R, 1998, THROMB HAEMOSTASIS, V79, P727
[2]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[3]   ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia [J].
Chapman, J ;
Wang, NS ;
Treves, TA ;
Korczyn, AD ;
Bornstein, NM .
STROKE, 1998, 29 (07) :1401-1404
[4]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[5]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[6]   Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease:: Evidence for an important genetic-environmental interaction [J].
Girelli, D ;
Friso, S ;
Trabetti, E ;
Olivieri, O ;
Russo, C ;
Pessotto, R ;
Faccini, G ;
Pignatti, PF ;
Mazzucco, A ;
Corrocher, R .
BLOOD, 1998, 91 (11) :4158-4163
[7]   Identification of cognitive impairment in the elderly: Homocysteine is an early marker [J].
Lehmann, M ;
Gottfries, CG ;
Regland, B .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (01) :12-20
[8]  
MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939
[9]  
Nishiyama M, 2000, J Epidemiol, V10, P163
[10]   Ethnic differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in healthy Israeli populations [J].
Pollak, RD ;
Friedlander, Y ;
Pollak, A ;
Idelson, M ;
Bejarano-Achache, I ;
Blumenfeld, A .
GENETIC TESTING, 2000, 4 (03) :309-311
12